Brief: XORTX Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
25/11/2022 22:55
Nov 25 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX ANNOUNCES RECEIPT OF NASDAQ NOTIFICATION REGARDING
MINIMUM
BID PRICE DEFICIENCY
Source text for Eikon: ID:nGNX242Rc6
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering
Brief: Xortx Announces Closing Of Acquisition Of Vectus Kidney Anti-Fibrotic Asset
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM